Pfizer’s And Novo’s Competing Bids For Metsera Devolve Into Lawsuits, Name Calling

New Action Claims Antitrust Violations

 
• By Mandy Jackson
  
Pfizer accused Novo of anticompetitive actions, while Novo called Pfizer's lawsuits "desperate" (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Deals